In another application, SERS nanostars were used for simultaneous detection of EGFR and programmed death-ligand 1 (PD-L1) in breast cancers using multiplexed detection of EGFR- and PD-L1-targeting antibody-labeled nanotags, respectively 183. This evidence concerns the gene EGFR and breast cancer.